Business Description
Sino Medical Sciences Technology Inc
ISIN : CNE100003NY2
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.64 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | -10.12 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 7.52 | |||||
Beneish M-Score | -2.84 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6 | |||||
3-Year FCF Growth Rate | 34 | |||||
3-Year Book Growth Rate | -8.7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 50.62 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.37 | |||||
9-Day RSI | 46.79 | |||||
14-Day RSI | 50.34 | |||||
3-1 Month Momentum % | 24.64 | |||||
6-1 Month Momentum % | 12.29 | |||||
12-1 Month Momentum % | -7.36 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.38 | |||||
Quick Ratio | 1.61 | |||||
Cash Ratio | 1.44 | |||||
Days Inventory | 264.96 | |||||
Days Sales Outstanding | 11.83 | |||||
Days Payable | 52.11 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -1.31 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.89 | |||||
Operating Margin % | -7.15 | |||||
Net Margin % | -1.11 | |||||
FCF Margin % | 0.29 | |||||
ROE % | -0.55 | |||||
ROA % | -0.37 | |||||
ROIC % | -0.69 | |||||
3-Year ROIIC % | -16.78 | |||||
ROC (Joel Greenblatt) % | -6.38 | |||||
ROCE % | -1.26 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 65.58 | |||||
PE Ratio without NRI | 2164 | |||||
PS Ratio | 8.15 | |||||
PB Ratio | 5.23 | |||||
Price-to-Tangible-Book | 20.04 | |||||
Price-to-Operating-Cash-Flow | 52.82 | |||||
EV-to-EBIT | -329.51 | |||||
EV-to-EBITDA | -329.51 | |||||
EV-to-Revenue | 10.73 | |||||
EV-to-FCF | 3771.53 | |||||
Price-to-GF-Value | 0.46 | |||||
Price-to-Graham-Number | 43.28 | |||||
Earnings Yield (Greenblatt) % | -0.3 | |||||
FCF Yield % | 0.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Sino Medical Sciences Technology Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 417.128 | ||
EPS (TTM) (Â¥) | -0.018 | ||
Beta | 1.27 | ||
3-Year Sharpe Ratio | 0.32 | ||
3-Year Sortino Ratio | 0.56 | ||
Volatility % | 50.6 | ||
14-Day RSI | 50.34 | ||
14-Day ATR (Â¥) | 0.500022 | ||
20-Day SMA (Â¥) | 10.868 | ||
12-1 Month Momentum % | -7.36 | ||
52-Week Range (Â¥) | 7.27 - 13.4 | ||
Shares Outstanding (Mil) | 413.46 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sino Medical Sciences Technology Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sino Medical Sciences Technology Inc Stock Events
Event | Date | Price (Â¥) | ||
---|---|---|---|---|
No Event Data |
Sino Medical Sciences Technology Inc Frequently Asked Questions
What is Sino Medical Sciences Technology Inc(SHSE:688108)'s stock price today?
When is next earnings date of Sino Medical Sciences Technology Inc(SHSE:688108)?
Does Sino Medical Sciences Technology Inc(SHSE:688108) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |